Recursive was Featured on Rise Consulting’s Website, Discussing the Utilization of AI in the Healthcare Sector

Recursive engaged in a discussion with the Japanese consulting firm Rise Consulting Group, Inc., on the topic of AI utilization and its future in the healthcare sector. The insights from this conversation have been featured on Rise Consulting's owned media platform, DIALOGUE.

The development of specialty care pharmaceuticals, including treatments for cancer, rare diseases, and intractable illnesses, continues to pose significant challenges for Japan's pharmaceutical industry. However, advancements in AI and digital technologies offer promising solutions to address these hurdles. Recursive is also exploring the potential of AI applications within the healthcare sector.

Tiago Ramalho, Co-founder and CEO of Recursive, and Takemasa Yuyama, Sales Director of Recursive, participated in the discussion with Osamu Takeguchi, Partner at Rise Consulting Group, and Jun Tsukahara, Manager at the same firm. The conversation covered a wide range of topics, including enhancing and streamlining drug development, utilizing AI in pharmaceutical sales and marketing activities, leveraging big data such as real-world data, and exploring AI's role in various healthcare applications.

Tiago enthusiastically also spoke about the potential of Recursive's AI technology in providing personalized medicine and assisting with clinical trial documentation, emphasizing the feasibility and impact of these innovations. The discussion served as a platform to explore the possibilities of AI-driven innovations in the healthcare industry and shared a collective vision for the future.

For more details, please visit Rise Consulting's website.

▶ RISE TALK 3: [Recursive Inc.] The Future and AI Utilization in the Healthcare Sector November 22, 2024 https://www.rise-cg.co.jp/digital-site/dialogue/risetalk_22/ (Japanese only)